Health Care for Type 1 Diabetes in Developing World
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study is a pilot 2-armed, randomized, open label, clinical trial evaluating the
effectiveness of a basal approach to diabetes management as compared to the current standard
treatment (regular/NPH).
Patients seen at the Association Rwandaise des Diabetiques (ARD) will be invited to
participate in the study and consent will be obtained by the investigation team. This will
continue until 40 patients have been enrolled at which time recruitment will be started at a
provincial hospital, at which 10 further participants will be recruited. Participants will be
consenting to 1) Randomization to basal or current insulin treatment arm and 2) Permission
for use of clinical data for research.Participants will be followed every six months for a
period of 24 months. The first 6 months will be a wash in period and participants will be
randomised (1/1) to their treatments at the 6 month visit.
Phase:
N/A
Details
Lead Sponsor:
University of Pittsburgh
Collaborators:
Association Rwandaise des Diabetiques National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National University, Rwanda